RGEN Repligen Corporation

NASDAQ

$189.68

Repligen Corporation (RGEN) Earnings News

Earnings press releases, previews and reviews for Repligen Corporation (RGEN), newest first.

Tuesday July 28, 2026 7:00 AM ET

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Wednesday July 22, 2026 6:00 AM ET

Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media

Wednesday July 15, 2026 7:30 AM ET

Repligen to Report Second Quarter 2026 Financial Results

Tuesday May 5, 2026 7:00 AM ET

Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Wednesday April 22, 2026 7:30 AM ET

Repligen to Report First Quarter 2026 Financial Results